Find clinical trials for Breast Cancer in Birmingham, AL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Birmingham, AL, USA:
This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...
Phase 2
Birmingham, Alabama, United States and 19 other locations
This is a randomized trial for patients with metastatic hormone receptor (HR)-positive human epidermal growth factor receptor 2 (HER2)-negative breast...
Phase 2
Birmingham, Alabama, United States and 12 other locations
to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...
Phase 2
Birmingham, Alabama, United States and 10 other locations
This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...
Phase 2
Birmingham, Alabama, United States and 9 other locations
and Lapatinib, given to participants with metastatic triple negative breast cancer that have undergone previous treatment. Velipari ...
Birmingham, Alabama, United States
This research study is studying a combination of drugs as a possible treatment for breast cancer.The drugs involved in this study a...
Phase 2
Birmingham, Alabama, United States and 16 other locations
In this research study we are studying the effects of the combination of lapatinib plus Herceptin in subjects with breast cancer th...
Phase 2
Birmingham, Alabama, United States and 8 other locations
together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...
Phase 2
Birmingham, Alabama, United States and 32 other locations
The human epidermal growth factor receptor 2 (HER2) regulates cell growth and survival. Approximately 15-20% of all breast cancers ...
Phase 1, Phase 2
Birmingham, Alabama, United States and 6 other locations
with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two pr...
Phase 2
Birmingham, Alabama, United States of America and 7 other locations
Clinical trials
Research sites
Resources
Legal